AI-powered triage solution for pneumothorax gains FDA clearance
Zebra Medical Vision has received FDA clearance for its new artificial intelligence (AI) solution that scans chest x-rays for signs of pneumothorax and alerts imaging providers when necessary.
This new AI-powered alert, HealthPNX, was designed to work with Zebra Medical’s All-in-One (AI1) worklist solution, flagging scans immediately for the radiologist. It was trained using millions of images, according to the company, to focus on 40 common findings associated with pneumothorax.
“We are happy to add this important capability to our All-in-One (AI1) package and add more value to busy radiology departments,” Eyal Gura, Zebra Medical’s CEO and co-founder, said in a prepared statement. “Health providers across the U.S. that already use the many Zebra-integrated PACS and worklist systems will be able to easily deploy our triage solution and improve their patient’s care and outcomes.”
“In a clinical validation study we performed, Zebra-Med’s acute CXR pneumothorax and CT Brain bleed products demonstrated a promising potential to substantially reduce turnaround time and increase the radiologist’s confidence in making these diagnoses,” Terence Matalon, MD, chairman of imaging at Albert Einstein Medical Center in Philadelphia, said in the same statement.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.